HER2 Positive Malignancies
2 clinical trials · Condition
◉ Watch HER2 Positive Malignancies
| Record | Firm | Date |
|---|---|---|
| Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors (NCT04684459) | Sichuan University | 2021-03-12 |
| Her2 and TGFBeta Cytotoxic T Cells in Treatment of Her2 Positive Malignancy (NCT00889954) | Baylor College of Medicine | 2009-05-01 |
Track HER2 Positive Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.